Estrogen receptor‐α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells

Acquired tamoxifen (TAM) resistance limits the therapeutic benefit of TAM in patients with hormone‐dependent breast cancer. The switch from estrogen‐dependent to growth factor‐dependent growth is a critical step in this process. However, the molecular mechanisms underlying this switch remain poorly...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Oncol
Glavni autori: Li, Guangliang, Zhang, Jing, Jin, Ketao, He, Kuifeng, Zheng, Yi, Xu, Xin, Wang, Haohao, Wang, Haiyong, Li, Zhongqi, Yu, Xiongfei, Teng, Xiaodong, Cao, Jiang, Teng, Lisong
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2013
Teme:
Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528464/
https://ncbi.nlm.nih.gov/pubmed/23499324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.02.001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items